![]() |
|||||||||||||
|
Acenocoumarol |
|
Acenocoumarol
|
|
| Systematic (IUPAC) name | |
| 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one | |
| Identifiers | |
| CAS number | |
| ATC code | B01 |
| PubChem | |
| Chemical data | |
| Formula | C19H15NO6 |
| Mol. mass | 353.326 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | 8 to 11 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist (like warfarin). It is a derivative of coumarin and is marketed under the brand names Sintrom and Sinthrome.
|
||||||||||||||||||||||||||||||||||||||||||